Skip to main content
logo
Sequana Medical NV (EBR:SEQUA)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.5740
-0.0200 (-3.37%)
Feb 10, 2026, 11:04 AM CET

Sequana Medical NV Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
-0.110.710.920.370.96
Revenue Growth (YoY)
--85.19%-22.81%149.04%-61.54%-0.76%
Cost of Revenue
00.030.160.20.080.2
Gross Profit
-00.080.550.720.290.76
Selling, General & Admin
16.4517.12625.4920.9116.71
Research & Development
1.481.684.043.853.211.86
Other Operating Expenses
------0.04
Operating Expenses
17.9418.7930.0429.3424.1118.53
Operating Income
-17.94-18.71-29.49-28.62-23.82-17.77
Interest Expense
-10.89-2.64-1.99-0.88-0.56-1.08
Interest & Investment Income
0.02-0000.01
Currency Exchange Gain (Loss)
-0.02-0.02-0-0.29-0.04-0.11
Other Non Operating Income (Expenses)
-22.77-23.01-0.62-0.581.19-
EBT Excluding Unusual Items
-51.59-44.37-32.1-30.38-23.22-18.95
Pretax Income
-51.59-44.37-32.1-30.38-23.22-18.95
Income Tax Expense
0.260.280.470.390.390.16
Net Income
-51.85-44.65-32.56-30.76-23.62-19.11
Net Income to Common
-51.85-44.65-32.56-30.76-23.62-19.11
Shares Outstanding (Basic)
473727231815
Shares Outstanding (Diluted)
473727231815
Shares Change (YoY)
54.42%37.26%17.59%25.02%18.96%24.51%
EPS (Basic)
-1.11-1.22-1.22-1.35-1.30-1.25
EPS (Diluted)
-1.11-1.22-1.22-1.35-1.30-1.25
Free Cash Flow
-17.69-20.35-29.77-28.16-23.94-17.14
Free Cash Flow Per Share
-0.38-0.55-1.11-1.24-1.31-1.12
Gross Margin
-74.94%76.95%77.83%79.31%78.99%
Operating Margin
--17731.38%-4141.06%-3102.32%-6428.78%-1844.86%
Profit Margin
--42325.70%-4572.43%-3334.08%-6373.84%-1983.45%
Free Cash Flow Margin
--19292.21%-4180.74%-3051.80%-6462.39%-1779.67%
EBITDA
-17.2-18.41-29.14-28.62-23.68-17.68
D&A For EBITDA
0.740.30.35-0.140.09
EBIT
-17.94-18.71-29.49-28.62-23.82-17.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.